獸醫生物標記市場 - 全球產業規模、佔有率、趨勢、機會和預測，按動物類型、產品類型、應用、疾病類型、地區和競爭進行細分，2020-2030 年預測

2024 年全球獸醫生物標記市場價值為 9.6553 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 12.30%。生物標記是可測量的指標，例如蛋白質、基因或代謝物，可用於檢測和量化動物的各種生理和病理過程。

主要市場促進因素

動物疾病和人畜共感染盛行率上升

主要市場挑戰

驗證和標準化

主要市場趨勢

即時診斷的興起

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球獸醫生物標記市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依動物類型（伴侶動物、生產動物）
  • 依產品類型（生物標記、試劑盒和試劑、生物標記讀取器）
  • 按應用（疾病診斷、臨床前研究、其他）
  • 依疾病類型（發炎及感染性疾病、心血管疾病、骨骼肌疾病、腫瘤、其他）
  • 按地區
  • 按公司分類（2024）
• 產品市場圖
  • 依動物類型
  • 依產品類型
  • 按應用
  • 依疾病類型
  • 按地區

第6章：北美獸醫生物標記市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 加拿大
  • 墨西哥

第 7 章：歐洲獸醫生物標記市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 英國
  • 法國
  • 義大利
  • 西班牙

第 8 章：亞太地區獸醫生物標記市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 日本
  • 印度
  • 澳洲
  • 韓國

第 9 章：南美洲獸醫生物標記市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲獸醫生物標記市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 科威特

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 合併與收購
• 產品發布

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Zoetis Inc.
• Virbac SA
• Life Diagnostics Inc
• Acuvet Biotech
• Merck & Co., Inc.
• IDEXX Laboratories, Inc.
• Mercodia AB
• Antech Diagnostics Inc

第 15 章：策略建議

第16章 關於出版商,免責事項

Global Veterinary Biomarkers Market was valued at USD 965.53 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 12.30% through 2030. The Global Veterinary Biomarkers Market refers to the sector within the veterinary healthcare industry that deals with the use of biomarkers for diagnosing diseases, monitoring animal health, and assessing treatment efficacy in animals. Biomarkers are measurable indicators, such as proteins, genes, or metabolites, that can be used to detect and quantify various physiological and pathological processes in animals.

Key Market Drivers

Rising Prevalence of Animal Diseases and Zoonotic Infections

The rising prevalence of animal diseases and zoonotic infections is a critical factor driving the growth of the Global Medical Scheduling Software Market. Globally, zoonotic diseases account for approximately one billion illness cases and millions of fatalities annually. Zoonoses comprise 60% of all newly emerging infectious diseases, underscoring their significant public health impact. Over the past 30 years, more than 30 novel human pathogens have been identified, with 75% originating from animals, highlighting the critical need for enhanced disease surveillance, veterinary healthcare advancements, and cross-sectoral collaboration to mitigate the risks of animal-to-human transmission. As veterinary clinics, hospitals, research centers, and government agencies strive to manage the increasing burden of infectious and chronic diseases in animals, the demand for efficient appointment scheduling, resource allocation, and workflow optimization is escalating. Below is an in-depth analysis of how the growing incidence of animal-related diseases is fueling the expansion of medical scheduling software in the veterinary and broader healthcare sectors.

Key Market Challenges

Validation and Standardization

Validating and standardizing biomarker assays for veterinary use is essential for ensuring accuracy and reliability. Establishing consistent standards and methodologies is challenging due to the diversity of animal species, breeds, and health conditions. This lack of standardization can hinder the widespread adoption of biomarker-based diagnostics and treatments.

Key Market Trends

Rise of Point-of-Care Diagnostics

Point-of-care diagnostics are revolutionizing veterinary medicine by providing rapid and on-site testing capabilities. These portable and user-friendly devices allow veterinarians to perform biomarker-based tests right in the clinic, enabling quicker diagnoses and immediate treatment decisions. The convenience of point-of-care testing is expected to drive its adoption in veterinary practices.

Key Market Players

• Zoetis Inc.
• Virbac SA
• Life Diagnostics Inc
• Acuvet Biotech
• Merck & Co., Inc.
• IDEXX Laboratories, Inc.
• Mercodia AB
• Antech Diagnostics Inc

Report Scope:

In this report, the Global Veterinary Biomarkers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Biomarkers Market, By Animal Type:

• Companion Animals
• Production Animals

Veterinary Biomarkers Market, By Product Type:

• Biomarkers
• Kits & Reagents
• Biomarker Readers

Veterinary Biomarkers Market, By Application:

• Disease Diagnostics
• Preclinical Research
• Others

Veterinary Biomarkers Market, By Disease Type:

• Inflammatory & Infectious Diseases
• Cardiovascular Diseases
• Skeletal Muscle Diseases
• Tumor
• Others

Veterinary Biomarkers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Biomarkers Market.

Available Customizations:

Global Veterinary Biomarkers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Biomarkers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Companion Animals, Production Animals)
  • 5.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
  • 5.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
  • 5.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Animal Type
  • 5.3.2. By Product Type
  • 5.3.3. By Application
  • 5.3.4. By Disease Type
  • 5.3.5. By Region

6. North America Veterinary Biomarkers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
  • 6.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
  • 6.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
  • 6.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Biomarkers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Disease Type
  • 6.3.2. Canada Veterinary Biomarkers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Disease Type
  • 6.3.3. Mexico Veterinary Biomarkers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Disease Type

7. Europe Veterinary Biomarkers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
  • 7.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
  • 7.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
  • 7.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Veterinary Biomarkers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Disease Type
  • 7.3.2. United Kingdom Veterinary Biomarkers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Disease Type
  • 7.3.3. France Veterinary Biomarkers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Disease Type
  • 7.3.4. Italy Veterinary Biomarkers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Disease Type
  • 7.3.5. Spain Veterinary Biomarkers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Disease Type

8. Asia-Pacific Veterinary Biomarkers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
  • 8.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
  • 8.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
  • 8.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Veterinary Biomarkers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Disease Type
  • 8.3.2. Japan Veterinary Biomarkers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Disease Type
  • 8.3.3. India Veterinary Biomarkers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Disease Type
  • 8.3.4. Australia Veterinary Biomarkers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Disease Type
  • 8.3.5. South Korea Veterinary Biomarkers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Disease Type

9. South America Veterinary Biomarkers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
  • 9.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
  • 9.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
  • 9.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Veterinary Biomarkers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Disease Type
  • 9.3.2. Argentina Veterinary Biomarkers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Disease Type
  • 9.3.3. Colombia Veterinary Biomarkers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Disease Type

10. Middle East and Africa Veterinary Biomarkers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type (Companion Animals (Dogs, Cats, Others), Production Animals (Cows, Pigs, Others))
  • 10.2.2. By Product Type (Biomarkers, Kits & Reagents, Biomarker Readers)
  • 10.2.3. By Application (Disease Diagnostics, Preclinical Research, Others)
  • 10.2.4. By Disease Type (Inflammatory & Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Others)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Veterinary Biomarkers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Disease Type
  • 10.3.2. Saudi Arabia Veterinary Biomarkers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Disease Type
  • 10.3.3. UAE Veterinary Biomarkers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Disease Type
  • 10.3.4. Kuwait Veterinary Biomarkers Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Animal Type
      • 10.3.4.2.2. By Product Type
      • 10.3.4.2.3. By Application
      • 10.3.4.2.4. By Disease Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Zoetis Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Virbac SA
• 14.3. Life Diagnostics Inc
• 14.4. Acuvet Biotech
• 14.5. Merck & Co., Inc.
• 14.6. IDEXX Laboratories, Inc.
• 14.7. Mercodia AB
• 14.8. Antech Diagnostics Inc

15. Strategic Recommendations

16. About Us & Disclaimer